Related Experiment Video
Updated: May 12, 2026

Establishing 3D Endometrial Organoids from the Mouse Uterus
Published on: January 6, 2023
The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth
Mitsuhiro Nakamura1, Masahiro Takakura, Reina Fujii
1Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.
Abstract:
Progestin inhibits the growth of normal and cancerous endometria via the progesterone receptor (PR), but the distinct functions and signalings of PR subtypes have not been fully understood. The aim of the present study was to dissect the key pathways of progestin to inhibit endometrial epithelial growth. Immortalized endometrial epithelial cells (EM-E6/E7/TERT) with stable PRA or PRB expression were established and used for the experiments. In vitro growth inhibition by progestin was mainly observed in EM-E6/E7/TERT cells with PRB rather than those with PRA. RT-PCR assay confirmed that FOXO1, a key gene for progestin action, was up-regulated by progestin in a PRB-dependent manner. cDNA microarray analysis identified IGFBP-1, which contains FOXO1 binding sites on its promoter, to be induced by medroxyprogesterone acetate (MPA) in EM-E6/E7/TERT cells with PRB but not with PRA. siRNA knockdown of FOXO1 disturbed the induction of IGFBP-1 by MPA, while IGFBP-1 knockdown showed no effect on MPA-induced FOXO1 expression, indicating that FOXO1 is an upstream regulator of IGFBP-1. Luciferase reporter assays showed that MPA activated the IGFBP-1 promoter, which was cancelled by FOXO1 knockdown. Chromatin immunoprecipitation assay confirmed the in vivo binding of FOXO1 to the core promoter of IGFBP-1. IGFBP-1 knockdown significantly attenuated the growth inhibitory effects of MPA. The FOXO1/IGFBP-1 axis is essential for PRB-dependent growth inhibition of endometrial epithelial cells, offering a potential therapeutic clue to enhance the progestin effect.
Insights
Progestin inhibits endometrial growth via progesterone receptor B (PRB), not PRA. The study reveals the FOXO1/IGFBP-1 pathway is crucial for PRB-mediated growth inhibition, offering therapeutic insights.
Area of Science:
- Endocrinology
- Molecular Biology
- Gynecologic Oncology
Background:
- Progestins regulate endometrial growth through progesterone receptors (PR).
- Distinct roles of PR subtypes (PRA and PRB) in endometrial proliferation remain unclear.
- Understanding PR signaling is vital for treating endometrial disorders.
Purpose of the Study:
- To elucidate the specific signaling pathways of progestin in inhibiting endometrial epithelial cell growth.
- To investigate the differential roles of PRA and PRB in mediating progestin's effects.
- To identify key molecular mediators of progestin-induced endometrial growth inhibition.
Main Methods:
- Established immortalized endometrial epithelial cells with stable PRA or PRB expression.
- Utilized RT-PCR, cDNA microarray, siRNA knockdown, luciferase reporter assays, and chromatin immunoprecipitation.
- Assessed in vitro cell growth inhibition following progestin treatment.
Main Results:
- Progestin-induced growth inhibition was primarily mediated by PRB, not PRA.
- Progestin upregulated FOXO1 in a PRB-dependent manner.
- The FOXO1/IGFBP-1 axis was identified as essential for PRB-mediated endometrial cell growth inhibition, with FOXO1 acting upstream of IGFBP-1.
Conclusions:
- PRB plays a dominant role in mediating progestin's growth-inhibitory effects on endometrial epithelial cells.
- The FOXO1/IGFBP-1 signaling axis is a critical downstream pathway for PRB function.
- Targeting the FOXO1/IGFBP-1 pathway may enhance progestin efficacy in endometrial therapies.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
TGF - β Signaling Pathway
Ovarian Cycle
Regulation of Angiogenesis and Blood Supply
Hedgehog Signaling Pathway

